Stockholders' Equity

9 Months Ended

Jul. 31, 2024

Stockholders' Equity Note [Abstract]

Stockholders' Equity

Note 9. Stockholders' Equity

Analysis of Changes in Accumulated Other Comprehensive Loss:

(In millions)	Foreign Currency Translation Adjustment		Minimum Pension Liability		Derivative Instruments		Total
Balance at October 31, 2022	$	(555.0)	$	(6.2)	$	94.4	$	(466.8)
Gross change in value	103.9		—		(15.7)		88.2
Tax effect	—		—		3.8		3.8
Balance at July 31, 2023	$	(451.1)	$	(6.2)	$	82.5	$	(374.8)
Balance at October 31, 2023	$	(538.0)	$	(3.2)	$	87.4	$	(453.8)
Gross change in value	62.5		—		(44.4)		18.1
Tax effect	—		—		10.6		10.6
Balance at July 31, 2024	$	(475.5)	$	(3.2)	$	53.6	$	(425.1)

Share Repurchases

In March 2017, the authorization under the 2012 Share Repurchase Program was increased to $1.0 billion by the Company's Board of Directors. As of July 31, 2024, $256.4 million remains authorized for repurchase.

During the three and nine months ended July 31, 2024, and 2023, there were no share repurchases.

Dividends    

In December 2023, the Company's Board of Directors decided to end the declaration of the semiannual dividend.

The Company paid dividends of approximately $1.5 million during the nine months ended July 31, 2023.